Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.

abstract：OBJECTIVE:Guanfacine has been shown to reduce hyperactive behaviors in children with attention-deficit/hyperactivity disorder (ADHD) and possibly in children with pervasive developmental disorder (PDD) and hyperactivity. The aim of this exploratory study was to examine whether gene variants encoding the multidrug resis...

journal_title：Journal of child and adolescent psychopharmacology

authors： McCracken JT,Aman MG,McDougle CJ,Tierney E,Shiraga S,Whelan F,Arnold LE,Posey D,Ritz L,Vitiello B,Scahill L

更新日期：2010-02-01 00:00:00

abstract：:Current estimates suggest that between 0.4% and 8.3% of children and adolescents are affected by major depression. We report a favorable response to treatment with citalopram by a 15-year-old boy with major depression who exhibited palpebral twitching during his first 2 weeks of treatment. This may have been a side ef...

journal_title：Journal of child and adolescent psychopharmacology

authors： Rojas VM,Silva R

更新日期：2001-10-01 00:00:00

abstract：: Objective: To explore blinded observational outcomes in the Treatment of Severe Childhood Aggression (TOSCA) study. Methods: During a 9-week acute trial, children with severe physical aggression and attention-deficit/hyperactiv...

journal_title：Journal of child and adolescent psychopharmacology

authors： Grondhuis SN,Farmer CA,Arnold LE,Gadow KD,Findling RL,Molina BSG,Kolko DJ,Buchan-Page KA,Rice RR , Jr,Butter EM,Aman MG

更新日期：2020-02-01 00:00:00

abstract：:Urinary catecholamine excretion was assessed in 15 boys with attention-deficit/hyperactivity disorder (ADHD) and 16 normal controls during a defined physical and mental task. Dihydroxyphenylalanine, dopamine, norepinephrine (NE), epinephrine (EPI), 3,4-dihydroxyphenylacetic acid, and 3,4-dihydroxyphenylglycol (DOPEG) ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Hanna GL,Ornitz EM,Hariharan M

更新日期：1996-04-01 00:00:00

abstract：OBJECTIVE:Post-mortem studies have reported abnormalities of the cholinergic system in autism. The purpose of this study was to assess the use of galantamine, an acetylcholinesterase inhibitor and nicotinic receptor modulator, in the treatment of interfering behaviors in children with autism. METHODS:Thirteen medicati...

journal_title：Journal of child and adolescent psychopharmacology

authors： Nicolson R,Craven-Thuss B,Smith J

更新日期：2006-10-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to examine immediate-release methylphenidate effectiveness during the 10-month open-label continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS). METHODS:One hundred and forty preschoolers with ADHD, who had improved with a...

journal_title：Journal of child and adolescent psychopharmacology

authors： Vitiello B,Abikoff HB,Chuang SZ,Kollins SH,McCracken JT,Riddle MA,Swanson JM,Wigal T,McGough JJ,Ghuman JK,Wigal SB,Skrobala AM,Davies M,Posner K,Cunningham C,Greenhill LL

更新日期：2007-10-01 00:00:00

abstract：:This article surveys the development of human hepatic P450 cytochromes (CYPs) involved in xenobiotic metabolism from the fetus through the life span and explores possible clinical consequences of developmental issues. These hepatic P450 CYPs come "on line" at different times during fetal and infant development, and ea...

journal_title：Journal of child and adolescent psychopharmacology

authors： Oesterheld JR

更新日期：1998-01-01 00:00:00

abstract：OBJECTIVE:The purpose of this article was to systematically review the literature on stimulant and atomoxetine combination therapy, in particular: 1) Characteristics of patients with attention-deficit/hyperactivity disorder (ADHD) given combination therapy, 2) treatment strategies used, 3) efficacy and effectiveness, a...

journal_title：Journal of child and adolescent psychopharmacology

authors： Treuer T,Gau SS,Méndez L,Montgomery W,Monk JA,Altin M,Wu S,Lin CC,Dueñas HJ

更新日期：2013-04-01 00:00:00

abstract：OBJECTIVE:Abnormal prefrontal and subcortical activity during cognitive control tasks is identified in non-depressed adolescents with bipolar disorder (BD); however, little is known about the neural correlates of bipolar adolescents in a depressed state (BDd). We aimed to investigate baseline versus after-treatment pat...

journal_title：Journal of child and adolescent psychopharmacology

authors： Diler RS,Segreti AM,Ladouceur CD,Almeida JR,Birmaher B,Axelson DA,Phillips ML,Pan L

更新日期：2013-04-01 00:00:00

abstract：:The potential for the induction of mania, increased cycle frequency, and other behavioral adverse events associated with antidepressant exposure in patients with bipolar disorder is becoming an increasingly important area of research study, as this diagnosis receives wider recognition in youth. While the majority of s...

journal_title：Journal of child and adolescent psychopharmacology

authors： Papolos DF

更新日期：2003-07-01 00:00:00

abstract：:Bipolar Disorders (BD) are often comorbid with disruptive behaviour disorders (DBDs) (oppositional-defiant disorder or conduct disorder), with negative implications on treatment strategy and outcome. The aim of this study was to assess the efficacy of quetiapine monotherapy in adolescents with BD comorbid with conduct...

journal_title：Journal of child and adolescent psychopharmacology

authors： Masi G,Pisano S,Pfanner C,Milone A,Manfredi A

更新日期：2013-10-01 00:00:00

abstract：BACKGROUND:Weight gain due to the use of second-generation antipsychotics is a major health care issue for adult and paediatric psychiatric patients. Little is known about long-term weight gain effects of aripiprazole compared to risperidone in children and adolescents. OBJECTIVE:The primary aim of this study is to as...

journal_title：Journal of child and adolescent psychopharmacology

authors： Schoemakers RJ,van Kesteren C,van Rosmalen J,Eussen MLJM,Dieleman HG,Beex-Oosterhuis MM

更新日期：2019-04-01 00:00:00

abstract：:Medication management of obsessive-compulsive disorder (OCD) has consisted of monotherapy with either clomipramine (CMI) or selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine, paroxetine, or sertraline. Frequently, OCD patients receiving monotherapy experience low treatment response rates and problema...

journal_title：Journal of child and adolescent psychopharmacology

authors： Figueroa Y,Rosenberg DR,Birmaher B,Keshavan MS

更新日期：1998-01-01 00:00:00

abstract：:In this single-case research study, we examined the efficacy and acceptability of sertraline treatment in children diagnosed with selective mutism. We utilized a double-blind, placebo-controlled trial of sertraline within a replicated multiple baseline/across participants research design (n = 2; n = 3). Multiple metho...

journal_title：Journal of child and adolescent psychopharmacology

authors： Carlson JS,Kratochwill TR,Johnston HF

更新日期：1999-01-01 00:00:00

abstract：: Objective: To guide clinicians in selecting the "next line" selective serotonin reuptake inhibitor (SSRI) for adolescents with treatment-resistant major depressive disorder, we sought to compare response rates among SSRIs in the Treatment of SSRI-Resistant Depression in Ad...

journal_title：Journal of child and adolescent psychopharmacology

authors： Strawn JR,Mills JA,Croarkin PE

更新日期：2019-05-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to retrospectively review a large sample of children and adolescents with pervasive developmental disorders (PDDs) treated with open-label guanfacine in order to gather preliminary data as to its effectiveness and safety. METHOD:Eighty (80) subjects with PDDs (10 females, 70 males) ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Posey DJ,Puntney JI,Sasher TM,Kem DL,McDougle CJ

更新日期：2004-07-01 00:00:00

abstract：:ABSTRACT The pertinent literature was reviewed on cardiovascular changes induced by psychostimulant medication treatment of hyperactive children. An assessment of 15 controlled studies using test doses of methylphenidate revealed a significant elevation of the resting heart rate in previously unmedicated children (mea...

journal_title：Journal of child and adolescent psychopharmacology

authors： Safer DJ

更新日期：1992-01-01 00:00:00

abstract：:Bipolar disorder (BP) in youth is an impairing psychiatric disorder associated with high rates of relapse and recurrence. High rates of psychiatric and medical co-morbidities account for additional illness burden in pediatric BP. The elevated risk of overweight and obesity in this population is of particular concern. ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein TR,Goldstein BI,Mantz MB,Bailey B,Douaihy A

更新日期：2011-06-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to investigate the course of autistic symptoms, using a quantitative measure of core autistic traits, among risperidone-treated children who participated in a 10 year life course longitudinal study. METHODS:Parents completed surveys of intervention history, as well as serial sym...

journal_title：Journal of child and adolescent psychopharmacology

authors： Marrus N,Underwood-Riordan H,Randall F,Zhang Y,Constantino JN

更新日期：2014-11-01 00:00:00

abstract：OBJECTIVE:Edivoxetine (LY2216684) is a selective and potent norepinephrine reuptake inhibitor (NERI). The pharmacokinetics (PK) and pharmacodynamics (PD) of edivoxetine were assessed in children and adolescent patients with attention-deficit/hyperactivity disorder (ADHD) following single and once-daily oral doses of ed...

journal_title：Journal of child and adolescent psychopharmacology

authors： Kielbasa W,Quinlan T,Jin L,Xu W,Lachno DR,Dean RA,Allen AJ

更新日期：2012-08-01 00:00:00

abstract：:ABSTRACT Current concerns about antidepressant efficacy in children and adolescents are reminiscent of the history of adult studies. Such awareness should temper these concerns, especially in view of the enormous progress in the last two decades of studies of adult depression. A number of methodologie, nosologie, deve...

journal_title：Journal of child and adolescent psychopharmacology

authors： Jensen PS,Ryan ND,Prien R

更新日期：1992-04-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to summarize results of a blinded review of potential suicidal events and analyses comparing incidence rates between paroxetine- and placebo-treated pediatric patients. METHOD:One thousand one hundred ninety-one (1191) children and adolescents received paroxetine (n = 642) or placeb...

journal_title：Journal of child and adolescent psychopharmacology

authors： Apter A,Lipschitz A,Fong R,Carpenter DJ,Krulewicz S,Davies JT,Wilkinson C,Perera P,Metz A

更新日期：2006-02-01 00:00:00

abstract：:The selective serotonin reuptake inhibitors (SSRIs) are becoming widely used in children and adolescents, with possible unexpected side effects being observed over time. SSRIs have been associated with bleeding in adults who have unremarkable routine hematologic laboratory results except abnormal bleeding time or plat...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lake MB,Birmaher B,Wassick S,Mathos K,Yelovich AK

更新日期：2000-04-01 00:00:00

abstract：BACKGROUND:The rate-corrected QT interval (QTc) prolongation is a risk factor for sudden cardiac death and may be induced by antipsychotic drugs. OBJECTIVE:To determine the clinical characteristics associated with QTc prolongation (440 msec or greater) in children and adolescents hospitalized for treatment of psychiat...

journal_title：Journal of child and adolescent psychopharmacology

authors： Correll CU,Harris J,Figen V,Kane JM,Manu P

更新日期：2011-08-01 00:00:00

abstract：PURPOSE:Amantadine has a growing body of evidence for the treatment of aggressive behavior in patients with traumatic brain injury, autism spectrum disorder, and developmental disability. We describe our experience with adjunctive amantadine treatment for aggressive behavior in eight hospitalized children. METHODS:We ...

journal_title：Journal of child and adolescent psychopharmacology

authors： McGrane IR,Loveland JG,Zaluski HJ

更新日期：2016-12-01 00:00:00

abstract：BACKGROUND:Recent evidence indicates that atypical antipsychotics represent a promising option for the treatment of autistic disorder. In particular, risperidone appears to be effective in treating aggressiveness, hyperactivity, irritability, stereotypies, social withdrawal, and lack of interests. OBJECTIVE:The aim of...

journal_title：Journal of child and adolescent psychopharmacology

authors： Gagliano A,Germanò E,Pustorino G,Impallomeni C,D'Arrigo C,Calamoneri F,Spina E

更新日期：2004-04-01 00:00:00

abstract：OBJECTIVES:This study examines cardiovascular (CV) effects of guanfacine immediate-release (GUAN-IR), dexmethylphenidate extended-release (DMPH), and their combination (COMB) during acute and long-term treatment of youth with attention-deficit/hyperactivity disorder. METHODS:Two hundred seven participants aged 7-14 ye...

journal_title：Journal of child and adolescent psychopharmacology

authors： Sayer GR,McGough JJ,Levitt J,Cowen J,Sturm A,Castelo E,McCracken JT

更新日期：2016-12-01 00:00:00

abstract：:Autism spectrum disorder (ASD) is commonly associated with a host of challenging behaviors. Pharmacotherapy is indicated if psychosocial and educational interventions fail. Atypical antipsychotics have the strongest evidence base so far, with both risperidone and aripiprazole being FDA approved. Unfortunately, their u...

journal_title：Journal of child and adolescent psychopharmacology

authors： Naguy A

更新日期：2017-06-01 00:00:00

abstract：OBJECTIVES:Studies have primarily focused on adverse life events (ALEs) as potential causes rather than as outcomes of pediatric depression. The current study prospectively examines ALEs in a sample of youth with attention-deficit/hyperactivity disorders (ADHD) to determine whether having a major depressive disorder (M...

journal_title：Journal of child and adolescent psychopharmacology

authors： Daviss WB,Diler R

更新日期：2012-02-01 00:00:00

abstract：OBJECTIVE:Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8-10 hours, and thereafter, provide a controlled, extended drug re...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pliszka SR,Wilens TE,Bostrom S,Arnold VK,Marraffino A,Cutler AJ,López FA,DeSousa NJ,Sallee FR,Incledon B,Newcorn JH

更新日期：2017-08-01 00:00:00